93

MetaMammography: Molecular Function Enhanced Mammography--Photon Imaging, Inc., 19355 Business Center Drive, Suite 8, Northridge, CA   91344; 818-709-2468, www.photonimaginginc.com
Dr. Bradley E. Patt, Principal Investigator, bradpatt@compuserve.com 
Dr. Jan S. Iwanczyk, Business Official, iwanczyk@compuserve.com 
DOE Grant No. DE-FG02-03ER83874
Amount:  $750,000 

By combining high detection rate with 98% sensitivity, relative low cost, safety, and widespread availability, x-ray mammography (XMM) has remained the mainstay of early breast cancer detection.  However, this technique has several limitations, particularly its low positive predictive value (20-50%).  During the past decade, numerous studies have shown that scintimammography (SMM), when used in conjunction with XMM, can significantly reduce the false-positive rate.  Because SMM has specificities and positive predictive values of 80-100%, this project will develop a combined scintimammography (SMM) digital x-ray mammography (DXMM) imaging system utilizing a dedicated breast gamma camera, a digital x-ray detector, and specialized camera bucky.  The system will provide co-registered SMM and XMM images without moving the breast. These images will be fused to provide a new type of mammogram showing microanatomy in gray scale overlayed with a threshold functional image using pseudocolor.   Phase I achieved a prototype system that demonstrated co-registered x-ray and gamma ray images.  A novel compression stage was used to position the breast for imaging by both the gamma camera and the digital x-ray camera.  Because the expected advantages are for screening  high-risk dense-breast patients, as opposed to diagnosis of suspicious lesions, the Phase II system will be optimized and scaled up for full-field-of-view mammography and scintimammography.  Once the hardware is constructed, a pilot clinical study of 150 patients will be conducted.

Commercial Applications and Other Benefits as described by awardee:  The new mammography system should address the need for improved breast cancer screening and diagnosis.  The market is extremely large with over 10,000 certified mammography facilities in the United States .